|会社名||CVS Health Corporation （CVS CVSヘルス）|
|業種||ヘルスケア施設_サ―ビス 医療関連（Health Care）|
|概要||事業概要 CVS・ヘルス（CVS Health Corporation）は子会社と共に運営する統合薬局医療会社である。同社はOmnicare Inc. (Omnicare)およびOmnicareの長期介護（LTC）事業を通じて、シニア・コミュニティへ医薬品の調達、関連薬局コンサルタントと慢性ケア施設、及びその他のケア施設への付帯サービスを含む薬局ケアを提供する。同社は調剤サービス、小売/LTC及び法人3つの事業を運営する。調剤サービス事業は、その顧客に対して多様な薬事給付管理（PBM）ソリューションを提供する。小売/LTC事業には9709の小売店舗（約7980店舗は薬局を運営し、1674店舗はTarget Corporation（Target）店舗に所在）、オンライン小売薬局ウェブサイト、CVS.com、Navarro.com、Onofre .com.br、オンサイト薬局店舗38店舗、長期ケア薬局事業、小売医療診療所などがある。 CVSヘルスは米国のドラッグストアチェ―ン・ヘルスケア大手。薬局サ―ビスは「CVS/pharmacy｣をはじめ調剤サ―ビス、薬剤給付プランの策定・管理、保険請求処理などの薬剤給付管理サ―ビスを提供。またCVS.comを通じて処方薬や一般医薬品、化粧品、雑貨、食品などを販売。店内の「ミニット・クリニック」で予防接種注射なども行う。 CVS Health is a different kind of health care company. It is a diversified health services company with nearly 300,000 employees united around a common purpose of helping people on their path to better health. In an increasingly connected and digital world, it is meeting people wherever they are and changing health care to meet their needs. Built on a foundation of unmatched community presence, its diversified model engages one in three Americans each year. From its innovative new services at HealthHUB locations, to transformative programs that help manage chronic conditions, it is making health care more accessible, more affordable and simply better.|
|本社所在地||One CVS Drive Woonsocket RI 02895 USA|
|代表者氏名||David Wyatt Dorman|
|代表者役職名||Independent Chairman of the Board|
|決算概要||決算概要 BRIEF: For the fiscal year ended 31 December 2018 CVS Health Corp revenues increased 5% to $194.58B. Net loss applicable to common stockholders excluding extraordinary items totaled $697M vs. income of $5.11B. Revenues reflect Retail Pharmacy Segment increase of 6% to $83.99B Pharmacy Services Segment increase of 3% to $134.13B Comp. Store Sales (Growth - %) - Pharmay increase from -2.6 to 7.9%.|
U.S. plans to stop buying Covid shots for the public this fall. Here''s what that means for you 2023/02/04 16:47:44 Kwhen Finance
Reach Stacker Market Value to Reach US$ 2.4 Bn by 2031, as per TMR Research Report 2023/02/03 12:40:00 Accesswire
WILMINGTON, DE / ACCESSWIRE / February 3, 2023 / Transparency Market Research Inc. - The global reach stacker market is projected to expand at a CAGR of 5.2% from 2022 to 2031, according to the market outlook presented in the research report by Transparency Market Research. Increase in adoption of biometrics, automated material handling devices, and GPS solutions has resulted in rapid expansion in the logistics industry. Reach stackers are gaining traction as drivers can receive and send data across networks with the help of IoT applications in a safe and secure manner. Demand for partially and fully autonomous reach stackers is likely to increase in the near future, which in turn is projected to drive market growth during the forecast period. Key Findings Increase in trade activities and rapid expansion of ports in emerging economies are likely to drive the demand for reach stackers during the forecast period. Moreover, the global industry is expected to witness significant business opportunities owing to increase in the number of containers at ports and rise in number of international companies that need equipment for container handling.
Missouri leads 20 AGs warning Walgreens, CVS about mailing abortion pills 2023/02/03 05:56:29 Alabama Today
Republican Missouri Attorney General Andrew Bailey and 19 other attorneys general are warning Walgreens and CVS pharmacies that any plans to mail abortion-inducing pills is illegal and unsafe. “As the principal legal and law enforcement officers of our 20 states, we offer you these thoughts on the current legal landscape,” Bailey wrote. In late January, […] The post Missouri leads 20 AGs warning Walgreens, CVS about mailing abortion pills appeared first on Alabama Today .
20 Republican attorneys general warn CVS, Walgreens against selling abortion pills by mail 2023/02/02 21:21:46 Azcentral
The letter, from Republican Missouri Attorney General Andrew Bailey, said selling the pills would violate abortion laws in the state.
GOP AGs Threaten Pharmacies If They Dispense Abortion Pills by Mail 2023/02/02 16:53:44 Common Dreams
A month after the two largest pharmacy chains in the United States announced their efforts to become certified to dispense abortion pills by mail, in accordance with a new Food and Drug Administration rule, the Republican attorneys general of 20 states on Wednesday warned the companies that providing the medications by mail in their states could result in legal action against them. In a letter co-signed by 19 attorneys general from states that have banned or attempted to ban abortion since the U.S. Supreme Court overturned Roe v. Wade last year, Attorney General Andrew Bailey of Missouri wrote to officials at Walgreens and CVS and suggested that they could face litigation if they follow new regulatory guidelines introduced by the FDA in early January. The agency announced last month that retail drugstores can dispense mifepristone and misoprostol—drugs used for medication abortions, which accounted for 51% of abortions in 2020 according to the Centers for Disease Control and Prevention.
2 Healthcare Stocks Analysts Favor Ahead of a Recession Year 2022/12/30 16:12:04 TipRanks
In this piece, we’ll make use of TipRanks’ Comparison Tool to have a glance at two stocks in the healthcare sector — CVS Health (NYSE:CVS) and Pfiz…
A top private equity investor predicts Big Tech will acquire a health company to defend against the recession, and 3 other M&A drivers in 2023 2022/12/30 06:41:43 Business Insider Nederlands
Insider asked private equity investor Fletcher Gregory about the future of healthcare in 2023. He predicted a wave of consolidation in digital health due to the economic downturn. He also said a big tech or retail company may be interested in a healthcare purchase. This year wasn’t a great one for deals in healthcare, as early companies struggled to find funding and delayed public debuts. That’s because the ups and downs in the stock market made for a challenging deal-making environment, according to Fletcher Gregory, a principal healthcare investor at General Atlantic, a private equity firm that invests in companies at earlier stages than traditional PE shops. The market volatility has made it harder to predict healthcare startups’ financial futures and valuations, critical components of M&A, he told Insider. But that’s all going to shift next year. In 2023, Gregory said four major trends will drive a “wave” of consolidation in digital health: slumping valuations; companies running out of cash; employers cutting their health budgets; and big tech firms and retailers continuing to move into healthcare to find new ways to grow.
CVS, 2 other brands of first aid kits recalled after FDA finds microbial contamination 2022/12/29 18:10:21 Fresno Bee
Six kinds of first aid kits sold under three brand names, including the CVS store brand, have been recalled because they include Easy Care AfterBurn Cream. FDA testing found microbial contamination in the cream.
Companies - Walmart, Walgreens, CVS, and more are locking away more products to deter theft - and it''s driving some customers away 2022/12/29 10:09:07 Business Mag
Waterpiks locked up at a Walgreens store in Louisville, Kentucky. Ben Tobin/Insider Retail theft led to roughly $94.5 billion in losses for retailers in 2021, per a recent NRF…
Walmart, Walgreens, CVS, and more are locking away more products to deter theft — and it''s driving some customers away 2022/12/29 10:00:00 Business Insider
Retailers battling surging theft are locking away items, and risk losing some customers over the inconvenience.
Adderall Shortage Worsens As People Without Drug "Not Able To Focus", May Impact Productivity 2022/09/16 01:20:00 Zero Hedge
Adderall Shortage Worsens As People Without Drug "Not Able To Focus", May Impact Productivity Adderal supplies in the US are dwindling as pharmacies and patients report shortages. The crux of the problem appears to be a major supplier of the drug for attention deficit/hyperactivity disorder has run into supply chain issues. Patients who find themselves without their medication might experience "withdraw" or even a "crash" that could impact productivity at work. The supply crunch first hit our radar last month when the National Community Pharmacists Association found hundreds of pharmacies across the US had trouble purchasing Adderall and generic versions of the brand in late July. Bloomberg spoke with a dozen patients in California, Indiana, and Michigan who were told by their local pharmacists at CVS Health Corp. or Walgreens Boots Alliance Inc. about a worsening drug shortage. "In some cases, patients were told they might have to wait more than a week to get their medication, which is supposed to be taken every day, " Bloomberg noted.
CVS, Walgreens cite Adderall shortages amid demand spike – Bloomberg 2022/09/15 18:10:05 Seeking Alpha
Popular ADHD drug Adderall is running low nationwide after a pandemic-era surge in demand and a labor shortage at the top manufacturer Teva Pharmaceutical (TEVA), Bloomberg…
CVS Health (CVS) Announces Acquisition of Signify Health Presentation - Slideshow (NYSE:CVS) 2022/09/15 17:37:59 Seeking Alpha
The following slide deck was published by CVS Health Corporation in conjunction with this event.
Better Buy: CVS Health vs. Walgreens Boots Alliance 2022/09/15 14:53:00 The Motley Fool
Which pharmacy retailer should you invest in?
関連キーワード （ヘルスケア施設_サ―ビス 米国株 CVS CVSヘルス CVS ）